Please be informed that the MedImpact program of covering the brand version of CRESTOR over generic ROSUVASTATIN CALCIUM ended on July 8, 2016 for Commercial and Marketplace clients. The program will continue for Medicare Part D clients.

As a result of the Kansas Department of Health and Environment’s (KDHE) Payment Reduction policy and effective July 1, 2016, Sunflower Health Plan will reduce Medicaid provider reimbursements for dates of service on and after July 1, 2016.

This week's update includes information on opioid legislation in Congress, A TRICARE pharmacy pilot, an AMP Final Rule from CMS, and more.

This week's Generic News features the Weekly Generics Campaign along with all of APCI's discounted generics, plus a free offer from Rx Express Marketing and news from FFF Enterprises.

In this week's update, learn about efforts from two Congressmen to get CMS to consider withdrawal of Humana's contract amendment, results of NCPA's survey on DIR fees, and more!